INSP (Inspire Medical Systems, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by INSP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Jason P Kelly | See Remarks | A | — | — |
| 2026-08-11 | Jason P Kelly | See Remarks | Sell | — | — |
| 2026-08-04 | Melissa Mann | Chief People Officer | F | — | — |
| 2026-07-27 | MICHAEL H CARREL | Director | A | — | — |
| 2026-07-17 | Shelley G Broader | Director | A | — | — |
| 2026-07-17 | Casey M Tansey | Director | A | — | — |
| 2026-07-17 | Georgia Melenikiotou | Director | A | — | — |
| 2026-07-17 | Gary Lee Ellis | Director | A | — | — |
| 2026-05-19 | John Rondoni | See Remarks | Sell | — | — |
| 2026-05-15 | John Rondoni | See Remarks | Sell | — | — |
| 2026-05-11 | Shawn mcCormick | Director | Sell | — | — |
| 2026-05-04 | Georgia Melenikiotou | Director | MIXED | — | — |
| 2026-05-04 | Shawn mcCormick | Director | A | — | — |
| 2026-05-04 | Shelley G Broader | Director | A | — | — |
| 2026-05-04 | Cynthia Burks | Director | A | — | — |
| 2026-05-04 | Myriam Curet | Director | A | — | — |
| 2026-05-04 | Casey M Tansey | Director | A | — | — |
| 2026-05-04 | Dana G Mead Jr. | Director | A | — | — |
| 2026-05-04 | Gary Lee Ellis | Director | A | — | — |
| 2026-04-16 | Casey M Tansey | Director | A | — | — |
| 2026-04-16 | Gary Lee Ellis | Director | A | — | — |
| 2026-04-16 | Georgia Melenikiotou | Director | A | — | — |
| 2026-04-16 | Shelley G Broader | Director | A | — | — |
| 2026-02-24 | John Rondoni | See Remarks | MIXED | — | — |
| 2026-02-24 | Carlton Weatherby | See Remarks | MIXED | — | — |
| 2026-02-24 | Melissa Mann | Chief People Officer | A | — | — |
| 2026-02-24 | Jason P Kelly | See Remarks | A | — | — |
| 2026-02-24 | Bryan K Phillips | See Remarks | MIXED | — | — |
| 2026-02-24 | Timothy P. Herbert | CEO and President | MIXED | — | — |
| 2026-02-18 | Bryan K Phillips | See Remarks | F | — | — |
| 2026-02-18 | Carlton Weatherby | See Remarks | F | — | — |
| 2026-02-18 | Jason P Kelly | See Remarks | F | — | — |
| 2026-02-18 | John Rondoni | See Remarks | F | — | — |
| 2026-02-18 | Melissa Mann | Chief People Officer | F | — | — |
| 2026-02-18 | Timothy P. Herbert | CEO and President | F | — | — |
| 2026-02-18 | Richard Buchholz | Interim CFO | F | — | — |
| 2026-02-11 | Richard Buchholz | Interim CFO | F | — | — |
| 2026-02-11 | John Rondoni | See Remarks | F | — | — |
| 2026-02-11 | Timothy P. Herbert | CEO and President | F | — | — |
| 2026-02-11 | Bryan K Phillips | See Remarks | F | — | — |
| 2026-02-11 | Carlton Weatherby | See Remarks | F | — | — |
| 2026-01-20 | Casey M Tansey | Director | A | — | — |
| 2026-01-20 | Shelley G Broader | Director | A | — | — |
| 2026-01-20 | Georgia Melenikiotou | Director | A | — | — |
| 2026-01-20 | Gary Lee Ellis | Director | A | — | — |
| 2026-01-12 | John Rondoni | See Remarks | Sell | — | — |
| 2025-12-04 | Shawn mcCormick | Director | Sell | — | — |
| 2025-12-01 | Shawn mcCormick | Director | Sell | — | — |
| 2025-11-24 | Myriam Curet | Director | MIXED | — | — |
| 2025-10-16 | Shelley G Broader | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,175,264 | — |
| — | Director | 2,096,810 | — |
| — | 10%+ Owner | 1,497,043 | — |
| — | 10%+ Owner | 1,161,157 | — |
| — | 10%+ Owner | 767,856 | — |
| — | 10%+ Owner | 750,795 | — |
| — | 10%+ Owner | 750,795 | — |
| — | 10%+ Owner | 232,216 | — |
| — | 10%+ Owner | 197,863 | — |
| — | Director | 158,500 | — |
| — | Director | 143,689 | — |
| — | CEO and President | 105,349 | — |
| — | Director | 86,539 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the INSP quote page; the site-wide leaderboard is on the insider transactions hub.